FDA

Why is my vyvanse not working? Vyvanse patent expired and FDA quickly approved 14 generics
ADHD News & Research

Vyvanse Generics Roll Out — And Disappoint

The new Vyvanse generic products hit the market in August 2023, shortly after the U.S. patent for Vyvanse expired. The FDA had quickly cleared 14  generic manufacturers, and readers soon started reporting their experiences with

Read More »
Mydayis from Takeda finally gets FDA approval. Triple-bead action
ADHD News & Research

Mydayis: Longer-Lasting Adderall

In case you missed it, there is a longer-lasting version of Adderall, called Mydayis. Many people report frustration with the current Adderall shortage.  I suggest that a trial of Mydayis would be worth a shot—and

Read More »
ADHD News & Research

Sound Off: Users of Downgraded Concerta Generics

  These first-person stories from generic Concerta users recount the dramatic and adverse changes they experienced—often not knowing why . This started around 2015.  Typically, those associating their devolved functioning with the different-looking “Concerta” pill

Read More »

Victory! Concerta Generics Downgraded!

The best news! The FDA announced today that the two approved generic versions of Concerta manufactured by Mallinckrodt Pharmaceuticals and Kudco have been downgraded. It’s horrifying that so many people have already been adversely affected,

Read More »

MORE FROM GINA

Stay in Touch!
Ride the ADHD Roller Coaster
Without Getting Whiplash!
Receive Gina Pera's award-winning blog posts and news of webinars and workshops.
P.S. Your time and privacy—Respected.
No e-mail bombardment—Promised.
No Thanks!
close-link